Orchid Pharma up 7% after good Q2 show; PAT up 26%, revenue rises 12%
The Earnings before interest, tax, depreciation, and amortisation (Ebitda) for the second quarter stood at Rs 30 crore as compared to Rs 24 crore a year ago which implies a rise of 25 per cent